GENB logo
NASDAQ · GENBBiotechnologyUpdated Nov 2, 2026

Generate Biomedicines, Inc. current ratio

Liquidity, historical trends, and peer comparisons.

The Current Ratio as of November 2026 (TTM) for Generate Biomedicines, Inc. (GENB) is 8.30

According to Generate Biomedicines, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.30. This represents a change of 63.42% compared to the average of 5.08 of the last 4 quarters.

Generate Biomedicines, Inc. (GENB) Historical Current Ratio (quarterly & annually)

How has GENB Current Ratio performed in the past?

The mean historical Current Ratio of Generate Biomedicines, Inc. over the last ten years is 3.78. The current 8.30 Current Ratio has changed 119.80% with respect to the historical average. Over the past ten years (40 quarters), GENB's Current Ratio was at its highest in in the March 2026 quarter at 9.17. The Current Ratio was at its lowest in in the March 2025 quarter at 0.

Quarterly (TTM)
Annual

Average

3.78

Median

3.78

Minimum

2.85

Maximum

4.70

Generate Biomedicines, Inc. (GENB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Generate Biomedicines, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Current Ratio = 4.70

Minimum Annual Increase = -39.39%

Minimum Annual Current Ratio = 2.85

Quarterly (TTM)
Annual
YearCurrent RatioChange
20252.85-39.39%

Generate Biomedicines, Inc. (GENB) Average Current Ratio

How has GENB Current Ratio performed in the past?

The current Current Ratio of Generate Biomedicines, Inc. (GENB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.78

5-year avg

3.78

10-year avg

3.78

Generate Biomedicines, Inc. (GENB) Current Ratio vs. Peers

How is GENB’s Current Ratio compared to its peers?

Generate Biomedicines, Inc.’s Current Ratio is less than Absci Corporation (10.63), greater than Inhibrx Biosciences Inc. (5.07), less than AbCellera Biologics Inc. (12.77), greater than Sutro Biopharma, Inc. (3.32),

Build a custom stock screener for Generate Biomedicines, Inc. (GENB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Generate Biomedicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Generate Biomedicines, Inc. (GENB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Generate Biomedicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Generate Biomedicines, Inc.'s Current Ratio?

How is the Current Ratio calculated for Generate Biomedicines, Inc. (GENB)?

What is the highest Current Ratio for Generate Biomedicines, Inc. (GENB)?

What is the 3-year average Current Ratio for Generate Biomedicines, Inc. (GENB)?

What is the 5-year average Current Ratio for Generate Biomedicines, Inc. (GENB)?

How does the current Current Ratio for Generate Biomedicines, Inc. (GENB) compare to its historical average?